GILD Financial Facts

Royalty revenues: 134.41M
Contract and other revenues: 3.66M
See Full Income Statement

Accrued compensation and employee benefits: 152.66M
Other long-term obligations: 213.33M
See Full Balance Sheet

Earnings History for Gilead Sciences Inc. (GILD)

  |   Expand Research on GILD
Next EPS Date 7/25/13 *Est. EPS Growth Rate -47.3% *Last Qtr.
Average EPS % Beat Rate +2.7% Revenue Growth Rate +11.0% *Last Qtr.
Average % Move 1-Wk after EPS +3.9%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/2/13 Q113 $0.48$0.50 -$0.02$2.53B$2.58B N/A / N/A N/A 0% Details
2/4/13 Q412 $0.50$0.48 +$0.02$2.59B$2.43B N/A / N/A N/A +30.8% Details
10/23/12 Q312 $1.00$0.94 +$0.06$2.43B$2.34B N/A / N/A N/A -20% Details
7/26/12 Q212 $0.99$0.95 +$0.04$2.41B$2.29B $0.94 / $2.31B N/A +0.1% Details
4/26/12 Q112 $0.91$0.94 -$0.03$2.28B$2.2B $0.90 / $2.19B N/A 0% Details
2/2/12 Q411 $0.97$1.05 -$0.08$2.2B$2.18B $1.07 / $2.21B N/A +5.1% Details
10/27/11 Q311 $1.02$1.01 +$0.01$2.12B$2.11B $1.04 / $2.15B N/A +23.5% Details
7/26/11 Q211 $1.00$0.99 +$0.01$2.14B$2.07B N/A / N/A N/A +23.1% Details
Like GILD Earnings? Also take a look at IDIX, BMY, VRTX, GSK

GILD Earnings News